Loading clinical trials...
Loading clinical trials...
A Clinical Study to learn if SEP-363856 has physical dependence in adults with schizophrenia. This study will be held in approximately 6 study sites in the United States. It will be accepting male and...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
NCT07565428 · Negative Symptoms of Schizophrenia
NCT07645443 · Early Onset Psychosis, First Psychotic Episode Within the Last 5 Years, and more
NCT06257056 · Treatment-Refractory Schizophrenia
NCT07288333 · Schizophrenia
NCT07105098 · Schizophrenia
Woodland International Research Group, LLC
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
Behavioral Clinical Research, Inc
Miami Lakes, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions